THE first doses of injectable ARVs, lenacapavir, have arrived in the country from the US, through the President’s Emergency Plan for AIDS Relief (PEPFAR). Lenacapavir is a long-acting injectable ARV that offers protection against HIV infection. In a statement, Wednesday, the US Department of State explained that the doses arriving in Zambia are part of a market-shaping initiative by PEPFAR to rapidly bring lenacapavir to market in ten high-HIV-burden countries. “The United States is announcing the delivery of the first doses of lenacapavir, an innovative drug produced by American company Gilead Sciences, to help prevent the spread of HIV. The doses arriving in Eswatini and Zambia are part of a market-shaping initiative by the President’s Emergency Plan for AIDS Relief...